Quantcast
Home / DC News / Justices: Generic drug design-defect claims preempted

Justices: Generic drug design-defect claims preempted

WASHINGTON — In a victory to generic pharmaceutical companies, the U.S. Supreme Court ruled today that state design-defect laws that impose a duty on generic drug makers to either change their labeling in violation of federal law or pull the drug from the market are preempted.
Scroll To Top